CSF1 and breast neoplasm: Median M-CSF levels were also reported to be dramatically higher in patients with newly diagnosed tumors of the head and neck, in men with prostate cancer metastatic to bone and women with advanced metastatic breast cancer than those seen in patients with newly diagnosed breast tumors (70).